Detalhe da pesquisa
1.
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays.
Front Immunol
; 14: 1170759, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37180152
2.
BNT162b2 Booster Vaccination Elicits Cross-Reactive Immunity Against SARS-CoV-2 Variants B.1.1.529 and B.1.617.2 in Convalescents of All Ages.
Front Immunol
; 13: 920210, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35795665